Rhesus disease: the model for fetal therapy.
During the past 40 years several therapeutic approaches have been tried in the management of rhesus-affected pregnancies, with the aim of ameliorating the severity of the condition and preventing intrauterine fetal death. These are reviewed below.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000649:Amniocentesis; D000740:Anemia / Q000209:etiology / Q000628:therapy; D001805:Blood Transfusion, Intrauterine / Q000379:methods; D016025:Bone Transplantation; D004899:Erythroblastosis, Fetal / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D004912:Erythrocytes / Q000503:physiopathology; D005260:Female; D005332:Fetoscopy; D005865:Gestational Age; D006085:Graft Survival; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007165:Immunosuppression Therapy; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control / Q000628:therapy*; D011263:Pregnancy Trimester, Third; D012203:Rh Isoimmunization / Q000503:physiopathology; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D014463:Ultrasonography
D000305:Adrenal Cortex Hormones; D012204:Rh-Hr Blood-Group System